Latest updates for Boehringer Ingelheim

Fresh curated links around Boehringer Ingelheim are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Supporting healthier, more productive dairy herds
  • <![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente
  • <![CDATA[Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

agriland.ie /3 weeks ago

Supporting healthier, more productive dairy herds

Boehringer Ingelheim Animal Health is proud to support the FBD National Dairy Show 2026 and looks forward to meeting farmers, veterinary professionals and members of the wider dair...

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Novartis &amp; BoomRay Enter Global License Agreement for Preclinical Radioligand Asset]]&gt;

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Roundup: Novartis &amp; Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Cl...

Read source
pharmexec.com /5 days ago

&lt;![CDATA[Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Roundup: Alteogen Enters Option &amp; License Agreement with Novartis, NewBiologix &amp; Synastra Form BioTe...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[InnoCare Enters $3.35 Billion Research Collaboration and License Agreement with Eli Lilly]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[M&amp;A Roundup: DualityBio &amp; Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Read source
pharmexec.com /4 weeks ago

&lt;![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

Read source
pharmexec.com /4 days ago

&lt;![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Read source
pharmexec.com /1 day ago

&lt;![CDATA[Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targ...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi &amp; Cheplapharm Form Strategic Part...

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum &amp; Incyte’s Atebrioz ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Roundup: AbbVie &amp; Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]&gt;

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]&gt;

Read source
pharmexec.com /1 week ago

&lt;![CDATA[Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Th...

Read source
law360.com /2 weeks ago

Chancery Allows Discovery In Boehringer Trade Secrets Fight

The Delaware Chancery Court Monday allowed Boehringer Ingelheim Pharmaceuticals Inc. to move ahead with discovery in its trade secrets fight against United Therapeutics Corp., but...

Read source
pharmexec.com /5 days ago

&lt;![CDATA[Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[BioNTech Terminates Phase II Clinical Trial for Cevumeran ]]&gt;

Read source
labiotech.eu /2 weeks ago

Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Faci...

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboa...

Read source
pharmexec.com /3 days ago

&lt;![CDATA[FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B]]&gt;

Read source
handelsblatt.com /1 month ago

Zukunftsgestalter: Weltspitze in der Provinz: Wie der größte Pharmakonzern Deutschlands seine Führungskräfte entwickelt

Deutschlands größter Pharmakonzern lockt erfolgreich Führungskräfte nach Ingelheim – und die bleiben dank spezieller Programme lange. Probieren Sie in einem Test aus, was dafür nöt...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Boehringer Ingelheim

agriland.ie

Recent coverage from public sources
Public source

handelsblatt.com

Recent coverage from public sources
Public source

labiotech.eu

Recent coverage from public sources
Public source

law360.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source